help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Osheroff, P. L.
Right arrow Articles by King, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osheroff, P. L.
Right arrow Articles by King, K. L.

Endocrinology, Vol 136, 4377-4381, Copyright © 1995 by Endocrine Society


ARTICLES

Binding and cross-linking of 32P-labeled human relaxin to human uterine cells and primary rat atrial cardiomyocytes

PL Osheroff and KL King
Department of Protein Chemistry, Genentech, Inc., South San Francisco, California 94080, USA.

Relaxin is known for its function in parturition and has been suggested to participate in the regulation of blood pressure, heart rate, and the release of neuropeptides such as oxytocin and vasopressin. Consistent with the physiological roles of relaxin, high affinity relaxin receptors have been demonstrated in the rat uterus, brain, and cardiac atrium. Here we report the binding and cross-linking of a biologically active, 32P-labeled human relaxin to a human uterine cell line and primary rat atrial cardiomyocytes. Relaxin binding to the human uterine cells consisted of a single class of high affinity sites (Kd = approximately 0.44 nM) with approximately 1082 +/- 62 binding sites/cell. Binding and cross-linking of relaxin to the human uterine cells and rat atrial cardiomyocytes followed by sodium dodecyl sulfate- polyacrylamide gel electrophoresis analysis revealed that the putative relaxin receptor showed a major component with an apparent M(r) greater than 220 kilodaltons and a minor component of approximately 36 kilodaltons, and was not disulfide linked. The binding and cross- linking of [32P]relaxin could be displaced by unlabeled relaxin in a concentration-dependent manner, but not by a 1000-fold molar excess of insulin, insulin-like growth factor I (IGF-I), or IGF-II. These data suggested that the relaxin receptor was similar in size but distinct from the insulin, IGF-I, and IGF-II receptors.


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers
International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides.
Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. P. Conrad and J. Novak
Emerging role of relaxin in renal and cardiovascular function
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. P. Bond, L. J. Parry, C. S. Samuel, H. M. Gehring, F. L. Lederman, P. A. W. Rogers, and R. J. Summers
Increased Expression of the Relaxin Receptor (LGR7) in Human Endometrium during the Secretory Phase of the Menstrual Cycle
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3477 - 3485.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
O. D. Sherwood
Relaxin's Physiological Roles and Other Diverse Actions
Endocr. Rev., April 1, 2004; 25(2): 205 - 234.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. T. Goldsmith, G. Weiss, S. Palejwala, T. M. Plant, A. Wojtczuk, W. C. Lambert, N. Ammur, D. Heller, J. H. Skurnick, D. Edwards, et al.
Relaxin regulation of endometrial structure and function in the rhesus monkey
PNAS, March 30, 2004; 101(13): 4685 - 4689.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
J. J. Luna, A. Riesewijk, J. A. Horcajadas, R. d. van Os, F. Dominguez, S. Mosselman, A. Pellicer, and C. Simon
Gene expression pattern and immunoreactive protein localization of LGR7 receptor in human endometrium throughout the menstrual cycle
Mol. Hum. Reprod., February 1, 2004; 10(2): 85 - 90.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Bartsch, B. Bartlick, and R. Ivell
Phosphodiesterase 4 Inhibition Synergizes with Relaxin Signaling to Promote Decidualization of Human Endometrial Stromal Cells
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 324 - 334.
[Abstract] [Full Text] [PDF]


Home page
Am J Sports MedHome page
J. L. Dragoo, R. S. Lee, P. Benhaim, G. A. M. Finerman, and S. L. Hame
Relaxin Receptors in the Human Female Anterior Cruciate Ligament
Am. J. Sports Med., July 1, 2003; 31(4): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. T. Nguyen, L. Yang, B. M. Sanborn, and C. W. Dessauer
Phosphoinositide 3-Kinase Activity Is Required for Biphasic Stimulation of Cyclic Adenosine 3',5'-Monophosphate by Relaxin
Mol. Endocrinol., June 1, 2003; 17(6): 1075 - 1084.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Einspanier, D. Muller, J. Lubberstedt, O. Bartsch, A. Jurdzinski, K. Fuhrmann, and R. Ivell
Characterization of relaxin binding in the uterus of the marmoset monkey
Mol. Hum. Reprod., October 1, 2001; 7(10): 963 - 970.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
O. Bartsch, B. Bartlick, and R. Ivell
Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity
Mol. Hum. Reprod., September 1, 2001; 7(9): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Hombach-Klonisch, S. Seeger, G. Tscheudschilsuren, J. Buchmann, B. Huppertz, G. Seliger, B. Fischer, and T. Klonisch
Cellular localization of human relaxin-like factor in the cyclic endometrium and placenta
Mol. Hum. Reprod., April 1, 2001; 7(4): 349 - 356.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. E. Bullesbach and C. Schwabe
Specific, High Affinity Relaxin-like Factor Receptors
J. Biol. Chem., August 6, 1999; 274(32): 22354 - 22358.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. N. Unemori, M. E. Erikson, S. E. Rocco, K. M. Sutherland, D. A. Parsell, J. Mak, and B. H. Grove
Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women
Hum. Reprod., March 1, 1999; 14(3): 800 - 806.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. Kohsaka,, G. Min,, G. Lukas,, S. Trupin,, E. T. Campbell,, and O. D. Sherwood
Identification of Specific Relaxin-Binding Cells in the Human Female
Biol Reprod, October 1, 1998; 59(4): 991 - 999.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Palejwala, D. Stein, A. Wojtczuk, G. Weiss, and L. T. Goldsmith
Demonstration of a Relaxin Receptor and Relaxin-Stimulated Tyrosine Phosphorylation in Human Lower Uterine Segment Fibroblasts
Endocrinology, March 1, 1998; 139(3): 1208 - 1212.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Parsell, J. Y. Mak, E. P. Amento, and ElaineN. Unemori
Relaxin Binds to and Elicits a Response from Cells of the Human Monocytic Cell Line, THP-1
J. Biol. Chem., November 1, 1996; 271(44): 27936 - 27941.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society